Corcept Therapeutics Incorporated (NASDAQ:CORT) Q3 2025 Earnings Call Transcript
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q3 2025 Earnings Call Transcript November 4, 2025Corcept Therapeutics Incorporated misses on earnings expectations.
Corcept Therapeutics Inc (CORT)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bailard Inc Thomas Bailard | 2,713 | $225,477 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $21.53 | 100,000 | $2,153,000.00 | 3,308,303 | 2021-06-11 | Filing | |
| $21.53 | 50,000 | $1,076,500.00 | 1,046,838 | 2021-06-11 | Filing | |
| $22.64 | 68 | $1,539.52 | 3,208,303 | 2020-12-01 | Filing | |
| $22.80 | 1,109 | $25,285.20 | 3,208,235 | 2020-11-30 | Filing | |
| $22.81 | 361 | $8,232.79 | 3,207,126 | 2020-11-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $76.28 | 300 | $22,884.00 | 5,287 | 2025-11-05 | Filing | |
| $75.64 | 13,164 | $995,678.89 | 5,587 | 2025-11-05 | Filing | |
| $74.75 | 6,536 | $488,558.81 | 18,751 | 2025-11-05 | Filing | |
| $73.65 | 5,000 | $368,244.50 | 10,277 | 2025-11-03 | Filing | |
| $75.98 | 3,590 | $272,759.94 | 2,741,370 | 2025-11-05 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,537,071 | $792,625,970 | 0.01% | |
| 2. | 849,864 | $70,632,217 | 0% | |
| 3. | 758,426 | $63,032,785 | 0.1% | |
| 4. | 601,499 | $49,990,559 | 0.01% | |
| 5. | 562,261 | $46,729,511 | 0.34% |
News See All
What Does Wall Street Think About Corcept Therapeutics (CORT)?
Corcept Therapeutics Incorporated (NASDAQ:CORT) is one of the best stocks to buy with over 50% upside potential.
10 Stocks to Buy With Over 50% Upside Potential
He stated that the market has begun to exhibit signs of increased speculation.
9 Most Profitable Biotech Stocks to Buy
On October 6, StemPoint Capital CIO Michelle Ross appeared on CNBC’s ‘Closing Bell’ to talk about the biotech space.
H.C. Wainwright Remains Bullish on Corcept Therapeutics Incorporated (CORT)
Corcept Therapeutics Incorporated (NASDAQ:CORT) is one of the best healthcare stocks with the highest upside. Corcept Therapeutics Incorporated (NASDAQ:CORT) received a rating update from H.C.
9 Best Healthcare Stocks with the Highest Upside
Talking about how people are feeling the impact of the shutdown, Dr.
Here’s What Makes Corcept Therapeutics (CORT) an Attractive Investment?
ClearBridge Investments, an investment management company, released its “Clearbridge Global Value Improvers Strategy” second-quarter 2025 investor letter.
Corcept Therapeutics Beats Q2 Estimates, Cuts Guidance and Advances NDA for New Cancer Drug
Corcept Therapeutics Incorporated (NASDAQ:CORT) reported its Q2 2025 earnings on July 31, 2025, in which it highlighted a 45% EPS beat, achieving $0.29 per share against an estimated $0.20.
12 Stocks with Consistent Growth to Invest In
Volatility of the market often decides the nature of stocks preferred by an investor.
11 Best Performing Long Term Stocks According to Analysts
Alli McCartney of UBS noted that the market’s behavior after the recent Fed rate cut was unusual. On the day of the cut, major indices closed lower except for the Russell 2000.
Hedge Fund Resource Center Billionaire Hedge Funds
